Digital Turbine To Be Added To S&P MidCap 400 Index; Gets Analyst Upgrades

Media and mobile communications company Digital Turbine Inc APPS will replace Ligand Pharmaceuticals Inc LGND in the S&P MidCap 400.
Ligand Pharmaceuticals will replace the acquisition target Cincinnati Bell Inc CBB in the S&P SmallCap 600.
The changes are effective before the opening of trading on September 7.
Canaccord Genuity analyst Austin Moldow upgraded Digital Turbine from Hold to Buy. Macquarie analyst Tim Nollen initiated coverage on Digital Turbine with a Neutral rating and announced a price target of $60.
Price Action: APPS shares traded higher by 10.30% at $56.50 in the premarket session on the last check Tuesday.